Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;56(3):130-4.
doi: 10.3345/kjp.2013.56.3.130. Epub 2013 Mar 18.

Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia

Affiliations

Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia

Woo Jung Jang et al. Korean J Pediatr. 2013 Mar.

Abstract

Purpose: Anthracyclines have been utilized in the treatment of children with acute lymphoblastic leukemia (ALL). Recent studies have shown that anthracyclines may induce toxicity in the vascular endothelium. This study was performed using brachial artery reactivity (BAR) to evaluate vascular endothelial function in ALL patients who were treated with anthracycline chemotherapy.

Methods: We included 21 children with ALL who received anthracycline chemotherapy and 20 healthy children. The cumulative dose of anthracyclines in the ALL patients was 142.5±18.2/m(2). The last anthracycline dose was administered to the patients 2 to 85 months prior to their examination using BAR. The diameter of the brachial artery was measured in both groups using echocardiography, and BAR was calculated as the percentage change in the arterial diameter after release of the cuff relative to the baseline vessel diameter.

Results: In the anthracycline-treated group, BAR was observed to be 3.4%±3.9%, which was significantly lower than that observed in the control group (12.1%±8.0%, P<0.05). The time elapsed after the last anthracycline treatment and the age at the time of treatment did not affect the change in BAR (P=0.06 and P=0.13, respectively).

Conclusion: These results provided evidence that treatment of ALL patients with anthracycline results in endothelial dysfunction. A larger cohort study and a longer follow-up period will be required to clarify the relationship between endothelial dysfunction resulting from anthracycline treatment for childhood ALL and occurrence of cardiovascular diseases later in life.

Keywords: Acute lymphoblastic leukemia; Anthracycline; Child; Vascular endothelium.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Brachial artery reactivity was higher in the control group than in the anthracycline-treated group (P<0.05). The vertical bar represents the values from the lower to upper quartile (25th to 75th percentile). The middle line represents the mean. The line extending between the minimum and maximum values includes the outside and far out values. The circles represent each value. BAR, brachial artery reactivity.
Fig. 2
Fig. 2
The correlation between elapsed time after the final anthracycline treatment and brachial artery reactivity (BAR) was not statistically significant (r=0.42, P=0.06).
Fig. 3
Fig. 3
The correlation between patient age at anthracycline administration and brachial artery reactivity (BAR) was not statistically significant (r=0.34, P=0.13).

Similar articles

Cited by

References

    1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–178. - PubMed
    1. Bhatia S. Late effects among survivors of leukemia during childhood and adolescence. Blood Cells Mol Dis. 2003;31:84–92. - PubMed
    1. Hatzipantelis ES, Athanassiou-Metaxa M, Gombakis N, Tzimouli V, Taparkou A, Sidi-Fragandrea V, et al. Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia. Acta Haematol. 2011;125:130–135. - PubMed
    1. Duquaine D, Hirsch GA, Chakrabarti A, Han Z, Kehrer C, Brook R, et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med. 2003;8:101–107. - PubMed
    1. Chow AY, Chin C, Dahl G, Rosenthal DN. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol. 2006;24:925–928. - PubMed

LinkOut - more resources